14 mars, 2022
Respiratorius AB (publ) develops drug candidates with the goal of launching drugs to treat common diseases such as cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. The project portfolio also includes a project for improving the diagnosis of certain cardiovascular diseases using PET imaging.
Scheelevägen 2, 223 81 Lund, Sweden
+46 70 922 41 40